Tapanainen JS - Search Results

1

Advances in the Molecular Pathophysiology, Genetics, and Treatment of Primary Ovarian Insufficiency.

Huhtaniemi I, Hovatta O, La Marca A, Livera G, Monniaux D, Persani L, Heddar A, Jarzabek K, Laisk-Podar T, Salumets A, Tapanainen JS, Veitia RA, Visser JA, Wieacker P, Wolczynski S, Misrahi M. Huhtaniemi I, et al. Among authors: tapanainen js. Trends Endocrinol Metab. 2018 Jun;29(6):400-419. doi: 10.1016/j.tem.2018.03.010. Epub 2018 Apr 26. Trends Endocrinol Metab. 2018. PMID: 29706485 Free article. Review.

2

The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.

Jaakkola T, Ding YQ, Kellokumpu-Lehtinen P, Valavaara R, Martikainen H, Tapanainen J, Rönnberg L, Huhtaniemi I. Jaakkola T, et al. J Clin Endocrinol Metab. 1990 Jun;70(6):1496-505. doi: 10.1210/jcem-70-6-1496. J Clin Endocrinol Metab. 1990. PMID: 2140831

3

Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure.

Aittomäki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, Kaskikari R, Sankila EM, Lehväslaiho H, Engel AR, Nieschlag E, Huhtaniemi I, de la Chapelle A. Aittomäki K, et al. Cell. 1995 Sep 22;82(6):959-68. doi: 10.1016/0092-8674(95)90275-9. Cell. 1995. PMID: 7553856 Free article.

4

Pituitary down-regulation with goserelin (Zoladex) for in vitro fertilisation.

Tapanainen JS, Hovatta O. Tapanainen JS, et al. Br J Obstet Gynaecol. 1994 May;101 Suppl 10:27-8. doi: 10.1111/j.1471-0528.1994.tb13682.x. Br J Obstet Gynaecol. 1994. PMID: 8199101 Review. No abstract available.

5

Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility.

Tapanainen JS, Aittomäki K, Min J, Vaskivuo T, Huhtaniemi IT. Tapanainen JS, et al. Nat Genet. 1997 Feb;15(2):205-6. doi: 10.1038/ng0297-205. Nat Genet. 1997. PMID: 9020851

6

Expression and hormonal regulation of transcription factors GATA-4 and GATA-6 in the mouse ovary.

Heikinheimo M, Ermolaeva M, Bielinska M, Rahman NA, Narita N, Huhtaniemi IT, Tapanainen JS, Wilson DB. Heikinheimo M, et al. Among authors: tapanainen js. Endocrinology. 1997 Aug;138(8):3505-14. doi: 10.1210/endo.138.8.5350. Endocrinology. 1997. PMID: 9231805

7

Inactivating FSH receptor mutations and gonadal dysfunction.

Tapanainen JS, Vaskivuo T, Aittomäki K, Huhtaniemi IT. Tapanainen JS, et al. Mol Cell Endocrinol. 1998 Oct 25;145(1-2):129-35. doi: 10.1016/s0303-7207(98)00179-8. Mol Cell Endocrinol. 1998. PMID: 9922109 Review.

8

The prevalence of polycystic ovaries in healthy women.

Koivunen R, Laatikainen T, Tomás C, Huhtaniemi I, Tapanainen J, Martikainen H. Koivunen R, et al. Acta Obstet Gynecol Scand. 1999 Feb;78(2):137-41. Acta Obstet Gynecol Scand. 1999. PMID: 10023877

9

Expression and regulation of transcription factors GATA-4 and GATA-6 in developing mouse testis.

Ketola I, Rahman N, Toppari J, Bielinska M, Porter-Tinge SB, Tapanainen JS, Huhtaniemi IT, Wilson DB, Heikinheimo M. Ketola I, et al. Among authors: tapanainen js. Endocrinology. 1999 Mar;140(3):1470-80. doi: 10.1210/endo.140.3.6587. Endocrinology. 1999. PMID: 10067876

10

A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone.

Tapanainen JS, Koivunen R, Fauser BC, Taylor AE, Clayton RN, Rajkowa M, White D, Franks S, Anttila L, Pettersson KS, Huhtaniemi IT. Tapanainen JS, et al. J Clin Endocrinol Metab. 1999 May;84(5):1711-5. doi: 10.1210/jcem.84.5.5702. J Clin Endocrinol Metab. 1999. PMID: 10323405 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

245 results

Search Page